3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thrombosis
2
Thromboembolism
2
Neoplasms
2
Vulvar Neoplasms
1
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombosis
1
Sarcoma
1
Pulmonary Embolism
1
Postoperative Complications
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Dalteparin
7
apixaban
5
Enoxaparin
3
edoxaban
2
Rivaroxaban
2
Aspirin
2
betrixaban
1
Warfarin
1
Platelet Transfusion
1
Heparin, Low-Molecular-Weight
1
Fondaparinux
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Venous Thromboembolism
×
Fondaparinux
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts